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Abstract Idiopathic nephrotic syndrome is the most com-
mon type of nephrotic syndrome in children and is often
associated with life threatening bacterial infections. While
the majority of children respond to prednisolone, most have
one or more relapses. In children with significant adverse
effects of prednisolone, corticosteroid sparing agents may
be required. A kidney biopsy is required to guide therapy in
those children, whose nephrotic syndrome fails to respond
to prednisolone.
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1 Case presentation
A three-year-old boy is brought to the emergency depart-
ment because of swelling around his eyes, which has been
present for two weeks. In the past 24 hours, the periorbital
swelling has become more marked with increasing redness
and the child has a fever to 38 degrees Celsius. The child’s
family doctor had diagnosed conjunctivitis and prescribed
some antibiotic eye drops. On examination in the emergency
department, the boy is noted to be irritable when examined
and to have edema of his legs extending to the thighs with
sacral edema and ascites. The cardiovascular and respira-
tory examinations are within normal limits with no evidence
of pleural effusions. The child’s weight is 15 kg (50th per-
centile) while his height is 88 cm (3rd percentile). His blood
pressure is 115/70.
2 Questions
(1) What are the most important two investigations to be
carried out immediately?
(A) Blood culture and urinalysis for blood and protein.
(B) Serum albumin and creatinine, urea and electrolytes.
(C) Full blood count and blood culture.
(D) Urinalysis for blood and protein and serum albumin.
(E) Creatinine, urea and electrolytes and serum choles-
terol.
(2) What is most likely to be the child’s diagnosis?
(A) Idiopathic nephrotic syndrome.
(B) Post infectious glomerulonephritis.




(3) What should be the first treatment given to this child?
(A) Intravenous antibiotics.
(B) Oral prednisolone.
(C) Intravenous albumin with frusemide.
(D) Intravenous antibiotics and oral prednisolone.
(E) Intravenous methylprednisolone or dexamethasone.
(4) Assuming that this child has idiopathic nephrotic syn-
drome, what should the initial prednisolone management
regimen be?
(A) Daily prednisolone for at least 4 weeks and then
cease.
(B) Daily prednisolone for at least 4 weeks followed by
alternate day prednisolone for at least 8 weeks.
(C) Daily prednisolone until the child achieves remission
(urine protein on dipstick zero or trace) and cease.
(D) Daily prednisolone until the child achieves remission
followed by 4 weeks of alternate day prednisolone.
(E) Alternate day prednisolone until the child achieves
remission.
(5) Before prednisolone and other corticosteroids were
available, most children with nephrotic syndrome died
because of bacterial infection. What steps can you take
to reduce the risk of severe infection?
(A) Ensure that the child has haemophilus influenzae
type B vaccination.
(B) Ensure that the child has vaccination against Pneu-
mococcus.
(C) Make sure that the family know to seek medical
attention when the child is febrile.
(D) Teach the family to recognize signs of relapse of
nephrotic syndrome.
(E) All of the above.
(6) The child achieves remission after 10 days. What is the
chance that this child will have frequent relapses (more
than 4 per year) or become steroid dependent (relapse
2 Clinics in Mother and Child Health







(7) The child relapses 3 months after presentation while
receiving alternate day prednisolone. After giving
another course of prednisolone to achieve remission,
how should this child be treated to maintain remission?
(A) Cyclophosphamide.
(B) Levamisole.
(C) Low dose alternate day prednisolone.
(D) Low dose daily prednisolone.
(E) Diuretics to control edema.
(8) Over the next two years the child continues to relapse
whenever the prednisolone dose is reduced below
0.7 mg/kg on alternate days. While growing well, he has
become obese with Cushingoid features and his parents
find that he is very aggressive to them and to his siblings.
What corticosteroid sparing therapy would you consider
first to achieve a prolonged period of remission?
(A) Cyclophosphamide.
(B) Cyclophosphamide or levamisole.
(C) A calcineurin inhibitor (cyclosporin or tacrolimus).
(D) Levamisole.
(E) Mycophenolic acid (mycophenolate mofetil or
mycophenolate sodium).
(9) This boy relapses within 3 months of completing
a 12-week course of cyclophosphamide and again
while receiving alternate day prednisolone after he
has achieved remission with daily prednisolone. What
corticosteroid sparing therapy is generally preferred as
a second line?
(A) A calcineurin inhibitor (cyclosporin or tacrolimus).
(B) Mycophenolic acid (mycophenolate mofetil or
mycophenolate sodium).
(C) Levamisole.
(D) A second course of cyclophosphamide.
(E) Rituximab.
(10) When would a kidney biopsy be considered essential
to guide therapy for a child with idiopathic nephrotic
syndrome?
(A) If he is steroid dependent.
(B) Before commencing corticosteroid sparing agents.
(C) If he fails to respond to prednisolone initially (initial
non-responder) or after one or more remissions with
prednisolone (late non-responder).
(D) At initial diagnosis of the nephrotic syndrome.
(E) To monitor nephrotoxicity during cyclosporin or
tacrolimus therapy.
3 Discussion
Nephrotic syndrome is characterized by massive protein-
uria, hypoalbuminemia and edema. Massive proteinuria
results from structural and functional defects in the
glomerular filtration barrier. While the liver tries to
compensate with increased albumin production, the loss
of urinary albumin exceeds the rate of synthesis, so serum
albumin drops and edema develops due to the reduced
oncotic pressure. The annual incidence of nephrotic
syndrome is around 2 per 100,000 children aged below
15 years in Europe and North America but is higher in
the Indian subcontinent and probably in other developing
countries.
Nephrotic syndrome in children may be caused by
a wide range of disorders, but the most common type
in children aged 1–10 years is idiopathic nephrotic
syndrome of which about 80% have steroid sensitive
nephrotic syndrome (SSNS) with minimal change disease
on renal biopsy. Other forms of idiopathic nephrotic
syndrome are focal and segmental glomerulosclerosis
(FSGS), mesangial proliferative glomerulonephritis,
membranoproliferative glomerulonephritis (MPGN) and
membranous glomerulonephritis (MN). There is some
evidence that the number of children with FSGS and steroid-
resistant nephrotic syndrome is increasing. Infectious
agents may cause nephrotic syndrome including hepatitis
B (associated with MN), hepatitis C (associated with
MPGN), HIV (associated with MPGN, MN, FSGS) and
malaria (associated with MN, MPGN). Mutations in genes
coding for proteins, including nephrin and podocin in the
glomerular filtration barrier, systemic diseases such as SLE
and medications (nonsteroidal antiflammatory agents), are
less common causes of nephrotic syndrome.
4 Grand rounds answers
Question (1): (A)
This child requires a urinalysis and blood culture imme-
diately. Bacterial infection usually with Pneumococcus or
haemophilus influenzae is common and serious in untreated
nephrotic syndrome in young children, who are dependent
on opsonins for splenic processing of these encapsulated
organisms. Opsonins and immunoglobulins as well as albu-
min are lost in the urine of nephrotic children. While the
other investigations listed are useful, the results do not usu-
ally change the immediate management.
Question (2): (C)
The child is likely to have idiopathic nephrotic syndrome
with periorbital cellulitis, though infectious causes of
nephrotic syndrome need to be excluded. Although the
child has a slightly elevated blood pressure and may have
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microscopic hematuria, these are common and transitory
in children presenting with idiopathic nephrotic syndrome.
Children with post infectious glomerulonephritis have much
less edema without ascites but their blood pressure is higher
reflecting the fact that the plasma volume is increased due
to reduced glomerular filtration rate. In idiopathic nephrotic
syndrome, edema occurs because of a reduced oncotic
pressure due to low plasma albumin, and plasma volume
is usually low. Severe IgA nephropathy presents as an
acute nephritic syndrome with hypertension, mild edema
and reduced renal function while severe SLE nephropathy
will also present as acute nephritis with additional features
including rash and arthropathy.
Question (3): (D)
The child should receive intravenous antibiotics (usually
penicillin) to treat the child’s periorbital cellulitis and also
commence oral prednisolone without delay. There are no
data to suggest that intravenous methylprednisolone or
dexamethasone is superior to oral prednisolone in achieving
remission. However, intravenous methylprednisolone might
be considered if the child does not tolerate oral medications.
Intravenous albumin (1 gm/kg infused over 4 hours) with
frusemide (1 mg/kg intravenously after 2 hours of infusion
and at the end of the infusion) may be required in very
edematous children with gross ascites and scrotal/penile or
labial edema. However, these medications should not be
used routinely. They can be considered if the renal function
is known to be normal and where experienced nursing
and/or medical supervision is available as pulmonary edema
and death may result.
Question (4): (B)
A systematic review [1] of six randomized controlled
trials has shown that the risk of relapse in the initial
episode of steroid sensitive nephrotic syndrome (SSNS)
is reduced by 30% at 12–24 months if prednisolone is
administered for at least three months when compared
with two months of prednisolone. An increase in benefit
is seen with administration for up to seven months. Daily
prednisolone given for one month followed by alternate
day prednisolone is more effective than giving prednisolone
till remission, followed by alternate day prednisolone.
Early observational studies suggested that alternate day
prednisolone given at double the dose of daily prednisolone
was effective, but this regimen has not been subjected to
randomized controlled trials. The usual starting dose of
prednisolone is 2 mg/kg or 60 mg/m2/day (given as a single
morning dose) for one month followed by alternate day
prednisolone for at least two months with a starting dose of
1.5 mg/kg or 40 mg/m2 given as a single morning dose on
alternate days.
Question (5): (E)
The most likely organisms to cause bacterial infections
are haemophilus influenzae type b and Streptococcus
pneumoniae (pneumococcus), which generally cause
infections (bacteremia, pneumonia, primary peritonitis)
when the child is in relapse. Therefore, it is essential that
children with nephrotic syndrome receive vaccinations
against these organisms. These vaccines can be given when
the child is receiving high dose prednisolone. Families
should be taught to seek early medical attention when the
child is febrile as bacteremia can progress rapidly. The
families should also have clear information on the signs
of a relapse of nephrotic syndrome and a simple plan of
management for a relapse.
Question (6): (C)
Of children presenting with idiopathic nephrotic syndrome,
80–90% will be responsive to prednisolone and are con-
sidered to have SSNS. Following remission, about 20% of
children do not have further relapses, 40% will relapse infre-
quently, while the remaining 40% will relapse frequently or
be steroid dependent. The risks of a child developing fre-
quent relapses or becoming steroid dependent are increased
with shorter time to first relapse, the number of relapses in
the first 6 months after initial treatment, younger age at the
initial episode, prolonged time to first remission, infection
at first relapse and male sex.
Question (7): (C)
It is recommended that in children with steroid-dependent
SSNS (SD SSNS), alternate day prednisolone be adminis-
tered in the lowest dose possible to maintain remission.
Following achievement of remission, prednisolone is
tapered to 0.5–0.7 mg/kg on alternate days or lower and
continued for 9–18 months with careful monitoring for
corticosteroid toxicity. Two randomized controlled trials
have demonstrated that daily prednisolone dose during
upper respiratory tract infection reduced the risk for relapse
in children with SD SSNS. Low dose daily prednisolone
may be used to maintain remission if alternate day dosing
is not effective. It is preferable to try low dose alternate
prednisolone before resorting to corticosteroid sparing
agents such as cyclophosphamide or levamisole. Because of
the risk of infection and the poor quality of life of children
in relapse, they should not receive diuretics to control edema
without other therapies.
Question (8): (B)
The alkylating agents (cyclophosphamide, chlorambucil),
the calcineurin inhibitors (cyclosporin, tacrolimus), levam-
isole and mycophenolic acid are effective as corticosteroid
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sparing agents in frequently relapsing and steroid-dependent
SSNS [2]. In randomized controlled trials and observational
studies they have been found to increase the duration of
remission compared with prednisolone alone. In general,
agents are combined with a reducing dose of prednisolone.
The choice of the initial agent depends on adverse effects,
availability and cost. In general, the initial agent used is
either cyclophosphamide or levamisole. Cyclophosphamide
is given for 12 weeks at a dose of 2 mg/kg/day and a
proportion of children will achieve a prolonged period
of remission off all treatment. Though generally well
tolerated, cyclophosphamide may cause leucopenia, hair
loss, hemorrhagic cystitis, increased risk of bacterial and
viral infections and reduced sperm counts. White blood
counts should be monitored every two weeks during
administration and the dose reduced if the white count falls
below 4.0 cells × 109/L and not increased again till the
white count exceeds 5.0 × 109/L. Cyclophosphamide is
preferred to chlorambucil since it has a slightly larger
window between therapeutic effect and toxicity. In
contrast, levamisole is associated with few adverse effects
with occasional reports of leucopenia, gastrointestinal
disturbance and rarely of cutaneous vasculitis. However, it
needs to be continued for 1–2 years since most children will
relapse when the medication is ceased. The dose used is
2.5 mg/kg on alternate days.
Question (9): (A)
While levamisole or mycophenolic acid may be given as
second line agents in this boy, most pediatric nephrologists
find either cyclosporin or tacrolimus to be the most useful
agents in children with SD SSNS. However, there are no
data from randomized controlled trials to confirm that
calcineurin inhibitors (CNI) are more effective than other
corticosteroid sparing agents. Cyclosporin is commenced
at 5 mg/kg/day in two divided doses while tacrolimus
is commenced at 0.1 mg/kg/day in two divided doses.
CNIs are associated with nephrotoxicity and hypertension.
Tacrolimus is often preferred because, unlike cyclosporin,
it does not cause gum hypertrophy and hirsutism. However,
it is associated with diabetes mellitus. Mycophenolic acid
(MPA) is increasingly being used in children with relapsing
SSNS though its relative efficacy to calcineurin inhibitors
is uncertain. It is associated with leucopenia, abdominal
pain and diarrhoea. CNIs and MPA are continued for
1–2 years and most children relapse when the medications
are ceased. Second courses of cyclophosphamide should not
be given because of the risk of reduced sperm counts and
infertility with a total cumulative dose exceeding 168 mg/kg
(equivalent to 2 mg/kg/day for 12 weeks). Rituximab is
a monoclonal antibody directed against B cells. Its use
should be reserved for children with SD SSNS, who have
continuing frequent relapses despite optimal combinations
of prednisone and corticosteroid sparing agents and/or
have serious adverse effects of therapy. CNIs, MPA and
rituximab are very expensive medications.
Question (10): (C)
A child who fails to respond to 8 weeks of prednisolone is
considered to be steroid resistant and should undergo a kid-
ney biopsy to determine the kidney pathology and the extent
of glomerular and tubulo-interstitial damage. In populations
including African populations where SSNS is less common,
some authors recommend that kidney biopsies should be
performed at initial diagnosis of nephrotic syndrome. Biop-
sies should be considered in children receiving CNIs who
show deteriorating kidney function particularly if this per-
sists when doses are reduced. Routine biopsies of children
with frequent relapsing or SD SSNS before using corticos-
teroid sparing therapy are not indicated. Studies show that
the most important predictor for kidney survival in SSNS is
not kidney pathology but the achievement and maintenance
of remission with prednisolone and other therapies.
References
[1] E. M. Hodson, N. S. Willis, and J. C. Craig, Corticosteroid therapy
for nephrotic syndrome in children, Cochrane Database Syst Rev,
4 (2007), CD001533.
[2] E. M. Hodson, N. S. Willis, and J. C. Craig, Non-corticosteroid
treatment for nephrotic syndrome in children, Cochrane Database
Syst Rev, 1 (2008), CD002290.
